The war in Iran has not yet significantly disrupted global pharmaceutical supply chains.[1][2] The short-term risk of drug shortages is low due to stockpiles such as mandatory stocks of essential medicines in the EU for 2 to 6 months.[2] Pharmaceutical companies hold an average of 180 days of inventory of finished drugs at manufacturing sites and supply chains.[2] Major distributors such as Cardinal, McKesson, and Cencora have approximately 25 to 30 days of inventory.[2] For example, the UAE has announced confidence in its emergency stockpile of medicines.[2] However, the conflict caused an increase in air transport prices from Asia to Europe by 45%.[2] An Iranian attack on the city of Ras Laffan in Qatar threatens the supply of helium, which is needed to cool MRI machines.[2] If the conflict is prolonged, there could be disruptions in the supply of sensitive drugs such as biologicals and vaccines.[1][2]